Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Fulcrum Therapeutics (FULC) Change in Intangibles (2019)

Fulcrum Therapeutics (FULC) has disclosed Change in Intangibles for 1 consecutive years, with $91000.0 as the latest value for Q1 2019.

Quarterly Change in Intangibles changed N/A to $91000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $91000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $91000.0 for FY2019, N/A changed from the prior year.
Change in Intangibles for Q1 2019 was $91000.0 at Fulcrum Therapeutics.
The five-year high for Change in Intangibles was $91000.0 in Q1 2019, with the low at $91000.0 in Q1 2019.